株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の核医学市場の分析と予測:製品(診断、治療薬)、用途別 2018年~2025年

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 726461
出版日 ページ情報 英文 137 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.24円で換算しております。
Back to Top
世界の核医学市場の分析と予測:製品(診断、治療薬)、用途別 2018年~2025年 Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025
出版日: 2018年08月31日 ページ情報: 英文 137 Pages
概要

世界の核医学市場は2018年から2025年にかけて10.1%のCAGRで推移し、2025年までに152億米ドル規模の市場に成長することが予測されています。核医学は癌や心血管疾患などの慢性疾患の診断および治療に幅広く利用されています。

当レポートでは、世界の核医学市場を調査し、市場の概要、製品・用途・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 調査方法
  • 調査範囲と前提
  • 略語のリスト

第2章 エグゼクティブサマリー

  • 市場概要

第3章 市場変数、動向、範囲

  • 市場区分

第4章 市場の定義

第5章 産業の展望

  • 成長要因の分析
    • 癌および心血管疾患の罹患率の上昇
    • 核医学の用途拡大
    • 正確な診断法に対するニーズの高まり
  • 阻害要因の分析
    • 生産、貯蔵、使用における厳格な規制
    • 核医学による診断・治療コストの高さ

第6章 ビジネス環境解析

  • SWOT分析
  • ファイブフォース分析
  • バリューチェーン分析

第7章 規制と政治的要因

  • 規制環境
  • 生産工程と動向

第8章 世界の核医学市場の分析と予測:製品別

  • 市場動向の分析:製品別

第9章 世界の核医学市場の分析と予測:用途別

  • 市場動向の分析:用途別

第10章 世界の核医学市場の分析と予測:地域別

  • 市場動向の分析:地域別

第11章 企業プロファイル

  • Eckert & Ziegler Group
  • Mallinckrodt
  • GE Healthcare
  • Jubilant Life Sciences Ltd.
  • Bracco Imaging S.P.A
  • Nordion, Inc.
  • The Institute For Radioelements (IRE)
  • Australian Nuclear Science & Technology Organization (ANSTO)
  • NTP Radioisotopes SOC Ltd.
  • Eczacibasi - Monrol

第12章 キーオピニオンリーダーの解説

  • 重要な分析
  • キーオピニオンリーダーの見解

第13章 推奨事項

図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 3 North America diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 4 North America SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 5 North America PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 6 North America therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 7 North America alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 8 North America beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 9 North America brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 10 North America nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 11 North America diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 12 North America therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 13 U.S. nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 14 U.S. diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 15 U.S. SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 16 U.S. PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 17 U.S. therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 18 U.S. alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 19 U.S. beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 20 U.S. brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 21 U.S. nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 22 U.S. diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 23 U.S. therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 24 Canada nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 25 Canada diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 26 Canada SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 27 Canada PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 28 Canada therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 29 Canada alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 30 Canada beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 31 Canada brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 32 Canada nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 33 Canada diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 34 Canada therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 35 Europe nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 36 Europe diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 37 Europe SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 38 Europe PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 39 Europe therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 40 Europe alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 41 Europe beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 42 Europe brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 43 Europe nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 44 Europe diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 45 Europe therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 46 Germany nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 47 Germany diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 48 Germany SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 49 Germany PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 50 Germany therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 51 Germany alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 52 Germany beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 53 Germany brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 54 Germany nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 55 Germany diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 56 Germany therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 57 U.K. nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 58 U.K. diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 59 U.K. SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 60 U.K. PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 61 U.K. therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 62 U.K. alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 63 U.K. beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 64 U.K. brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 65 U.K. nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 66 U.K. diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 67 U.K. therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 68 France nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 69 France diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 70 France SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 71 France PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 72 France therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 73 France alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 74 France beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 75 France brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 76 France nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 77 France diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 78 France therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 79 Italy nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 80 Italy diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 81 Italy SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 82 Italy PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 83 Italy therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 84 Italy alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 85 Italy beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 86 Italy brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 87 Italy nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 88 Italy diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 89 Italy therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 90 Spain nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 91 Spain diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 92 Spain SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 93 Spain PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 94 Spain therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 95 Spain alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 96 Spain beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 97 Spain brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 98 Spain nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 99 Spain diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 100 Spain therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 101 Russia nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 102 Russia diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 103 Russia SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 104 Russia PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 105 Russia therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 106 Russia alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 107 Russia beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 108 Russia brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 109 Russia nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 110 Russia diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 111 Russia therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 112 Netherlands nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 113 Netherlands diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 114 Netherlands SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 115 Netherlands PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 116 Netherlands therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 117 Netherlands alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 118 Netherlands beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 119 Netherlands brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 120 Netherlands nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 121 Netherlands diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 122 Netherlands therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 123 Asia Pacific nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 124 Asia Pacific diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 125 Asia Pacific SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 126 Asia Pacific PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 127 Asia Pacific therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 128 Asia Pacific alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 129 Asia Pacific beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 130 Asia Pacific brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 131 Asia Pacific nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 132 Asia Pacific diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 133 Asia Pacific therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 134 Japan nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 135 Japan diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 136 Japan SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 137 Japan PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 138 Japan therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 139 Japan alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 140 Japan beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 141 Japan brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 142 Japan nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 143 Japan diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 144 Japan therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 145 China nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 146 China diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 147 China SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 148 China PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 149 China therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 150 China alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 151 China beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 152 China brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 153 China nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 154 China diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 155 China therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 156 Latin America nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 157 India diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 158 India SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 159 India PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 160 India therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 161 India alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 162 India beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 163 India brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 164 India nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 165 India diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 166 India therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 167 Australia nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 168 Australia diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 169 Australia SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 170 Australia PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 171 Australia therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 172 Australia alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 173 Australia beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 174 Australia brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 175 Australia nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 176 Australia diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 177 Australia therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 178 Singapore nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 179 Singapore diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 180 Singapore SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 181 Singapore PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 182 Singapore therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 183 Singapore alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 184 Singapore beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 185 Singapore brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 186 Singapore nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 187 Singapore diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 188 Singapore therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 189 Malaysia nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 190 Malaysia diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 191 Malaysia SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 192 Malaysia PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 193 Malaysia therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 194 Malaysia alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 195 Malaysia beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 196 Malaysia brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 197 Malaysia nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 198 Malaysia diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 199 Malaysia therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 200 New Zealand nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 201 New Zealand diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 202 New Zealand SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 203 New Zealand PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 204 New Zealand therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 205 New Zealand alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 206 New Zealand beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 207 New Zealand brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 208 New Zealand nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 209 New Zealand diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 210 New Zealand therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 211 Korea nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 212 Korea diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 213 Korea SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 214 Korea PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 215 Korea therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 216 Korea alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 217 Korea beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 218 Korea brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 219 Korea nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 220 Korea diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 221 Korea therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 222 Phillippines nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 223 Phillippines diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 224 Phillippines SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 225 Phillippines PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 226 Phillippines therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 227 Phillippines alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 228 Phillippines beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 229 Phillippines brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 230 Phillippines nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 231 Phillippines diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 232 Phillippines therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 233 Latin America nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 234 Latin America diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 235 Latin America SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 236 Latin America PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 237 Latin America therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 238 Latin America alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 239 Latin America beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 240 Latin America brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 241 Latin America nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 242 Latin America diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 243 Latin America therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 244 Brazil nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 245 Brazil diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 246 Brazil SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 247 Brazil PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 248 Brazil therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 249 Brazil alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 250 Brazil beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 251 Brazil brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 252 Brazil nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 253 Brazil diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 254 Brazil therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 255 Argentina nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 256 Argentina diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 257 Argentina SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 258 Argentina PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 259 Argentina therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 260 Argentina alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 261 Argentina beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 262 Argentina brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 263 Argentina nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 264 Argentina diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 265 Argentina therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 266 Mexico nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 267 Mexico diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 268 Mexico SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 269 Mexico PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 270 Mexico therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 271 Mexico alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 272 Mexico beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 273 Mexico brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 274 Mexico nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 275 Mexico diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 276 Mexico therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 277 South Africa nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 278 South Africa diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 279 South Africa SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 280 South Africa PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 281 South Africa therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 282 South Africa alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 283 South Africa beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 284 South Africa brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 285 South Africa nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 286 South Africa diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 287 South Africa therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 288 Israel nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 289 Israel diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 290 Israel SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 291 Israel PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 292 Israel therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 293 Israel alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 294 Israel beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 295 Israel brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 296 Israel nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 297 Israel diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 298 Israel therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 299 Turkey nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 300 Turkey diagnostic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 301 Turkey SPECT market, by product,2014 - 2025 (USD Million/ Volume in Ci)
  • Table 302 Turkey PET market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 303 Turkey therapeutic nuclear medicine market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 304 Turkey alpha emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 305 Turkey beta emitters market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 306 Turkey brachytherapy market, by product, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 307 Turkey nuclear medicine market, by application, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 308 Turkey diagnostic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)
  • Table 309 Turkey therapeutic application market, by type, 2014 - 2025 (USD Million/ Volume in Ci)

List of Figures

  • Fig.1 Radiopharmaceuticals Market snapshot
  • Fig.2 Radiopharmaceuticals market segmentation
  • Fig.3 Radiopharmaceuticals market driver impact
  • Fig.4 Global Cancer Prevalence projection,2015 - 2025 (Number of registered cases)
  • Fig.5 Radiopharmaceuticals market restraint impact
  • Fig.6 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig.7 Porter's Five Forces Analysis
  • Fig.8 Value Chain Analysis
  • Fig.9 Radiopharmaceuticals Market: Production of Tc - 99 (SPECT radioisotopes)
  • Fig.10 Radiopharmaceuticals Market: Production of Mo - 99
  • Fig.11 Radiopharmaceuticals Market: Production of Mo - 98
  • Fig.12 Radiopharmaceuticals market: product outlook and key takeaways
  • Fig.13 Radiopharmaceuticals Market: Product Movement Analysis
  • Fig.14 Diagnostic products market, 2013 - 2025 (USD Million)
  • Fig.15 SPECT products market, 2013 - 2025 (USD Million)
  • Fig.16 TC - 99m market, 2013 - 2025 (USD Million)
  • Fig.17 TL - 201 market, 2013 - 2025 (USD Million)
  • Fig.18 GA - 67 market, 2013 - 2025 (USD Million)
  • Fig.19 I - 123 market, 2013 - 2025 (USD Million)
  • Fig.20 Other SPECT products market, 2013 - 2025 (USD Million)
  • Fig.21 PET products market, 2013 - 2025 (USD Million)
  • Fig.22 - F - 18 market, 2013 - 2025 (USD Million)
  • Fig.23 SR - 82/RB - 82 market, 2013 - 2025 (USD Million)
  • Fig.24 Other PET products market, 2013 - 2025 (USD Million)
  • Fig.25 Therapeutic products market, 2013 - 2025 (USD Million)
  • Fig.26 Alpha emitters market, 2013 - 2025 (USD Million)
  • Fig.27 RA - 223 market, 2013 - 2025 (USD Million)
  • Fig.28 Other alpha emitters market, 2013 - 2025 (USD Million)
  • Fig.29 Beta emitters market, 2013 - 2025 (USD Million)
  • Fig.30 I - 131 market, 2013 - 2025 (USD Million)
  • Fig.31 Y - 90 market, 2013 - 2025 (USD Million)
  • Fig.32 SM - 153 market, 2013 - 2025 (USD Million)
  • Fig.33 Re - 186 market, 2013 - 2025 (USD Million)
  • Fig.34 Lu - 177 market, 2013 - 2025 (USD Million)
  • Fig.35 Other beta emitters market, 2013 - 2025 (USD Million)
  • Fig.36 Brachytherapy market, 2013 - 2025 (USD Million)
  • Fig.37 Cesium - 131 market, 2013 - 2025 (USD Million)
  • Fig.38 Iodine - 125 market, 2013 - 2025 (USD Million)
  • Fig.39 Palladium - 103 market, 2013 - 2025 (USD Million)
  • Fig.40 Iridium - 192 market, 2013 - 2025 (USD Million)
  • Fig.41 Other Brachytherapy Products Market, 2013 - 2025 (USD Million)
  • Fig.42 Radiopharmaceuticals market: application outlook and key takeaways
  • Fig.43 Radiopharmaceuticals Market: Application Movement Analysis
目次
Product Code: GVR-1-68038-086-6

The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a 10.1% CAGR during the forecast period. The burden of chronic diseases such as cancer and cardiac disorders is on a rise. Nuclear medicine is widely used for diagnosis as well as treatment of such disorders.

Increasing prevalence of these disorders has a direct impact on usage of radiopharmaceuticals. As per data published by the World Health Organization (WHO), cancer is the second leading cause of death around the globe and in 2015, accounted for 8.8 million deaths. This is anticipated to drive demand for radiopharmaceuticals in the years to come.

Diagnostics, when combined with nuclear medicine, improve accuracy to a great extent. This can have a direct impact on decision-making and treatment monitoring processes. Adoption of PET as a diagnostic tool is rapidly increasing since it has shown greater precision over other diagnostic techniques.

Further key findings from the report suggest:

  • By product, the nuclear medicine market was dominated by the diagnostic segment in 2015, driven primarily by advancements in scanning technologies
  • The therapeutic segment, which comprises alpha emitters, beta emitters, and brachytherapy, is anticipated to exhibit lucrative growth over the coming years
  • On the basis of application, diagnostic formed the largest segment in 2015, including key areas such as cardiology, neurology, oncology, and thyroid
  • North America dominated the global radiopharmaceuticals market in 2015 owing to well-planned policies, favorable reimbursement structure, high healthcare spending, and increasing awareness
  • Asia Pacific is expected to witness lucrative growth in the coming years. Increasing per capita income and reform in policies is attracting market players

Key players in the industry include: Eckert & Ziegler Group; Mallinckrodt Pharmaceuticals; GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A; and Nordion, Inc.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Scope And Assumptions
  • 1.3 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook

  • 5.1 Market Variable Analysis
    • 5.1.1 Rising Incidence Of Cancer And Cardiovascular Disease
    • 5.1.2 Widening Applications Of Radiopharmaceuticals
    • 5.1.3 Growing Demand For The Accurate Diagnostic Methods
  • 5.2 Market Restraint Analysis
    • 5.2.1 Stringent Regulation For Production, Storage, And Usage
    • 5.2.2 High Cost Involved With Diagnostics And Therapeutic Procedures

Chapter 6 Business Environment Aanalysis

  • 6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 6.2 Porter's Five Forces Analysis
  • 6.3 Value Chain Analysis

Chapter 7 Regulatory And Political Forces

  • 7.1 Regulatory Landscape
    • 7.1.1 List Of Factors/ Regulations By Country
      • 7.1.1.1 North America
      • 7.1.1.1.1 U.S.
      • 7.1.1.1.2 Canada
      • 7.1.1.2 Europe
      • 7.1.1.3 Asia Pacific
      • 7.1.1.3.1 China
      • 7.1.1.3.2 Japan
      • 7.1.1.3.3 India
      • 7.1.1.3.4 Australia/New Zealand
      • 7.1.1.3.5 Korea
      • 7.1.1.3.6 Singapore
      • 7.1.1.3.7 Malaysia
      • 7.1.1.3.8 Philippines
      • 7.1.1.4 Middle East & Africa
      • 7.1.1.4.1 South Africa
      • 7.1.1.4.2 Gcc
      • 7.1.1.5 Latin America
      • 7.1.1.5.1 Brazil
      • 7.1.1.5.2 Mexico
      • 7.1.1.5.3 Argentina
  • 7.2 Production Process And Trends
    • 7.2.1 Production Process And Trends
      • 7.2.1.1 Production Of Mo - 99 (SPECT Radioisotopes)
      • 7.2.1.2 SPECT Radioisotopes Trends
      • 7.2.1.3 PET Radioisotopes Trends
      • 7.2.1.4 Therapeutic Radioisotopes Trends
      • 7.2.1.5 Latest Developments

Chapter 8 Product Business Analysis

  • 8.1 Radiopharmaceuticals Market: Product Movement Analysis
    • 8.1.1 Diagnostic Products
      • 8.1.1.1 Diagnostic Products Market, 2013 - 2025 (USD Million)
      • 8.1.1.2 SPECT
      • 8.1.1.3 SPECT Products Market, 2013 - 2025 (USD Million)
      • 8.1.1.4 TC - 99m
      • 8.1.1.4.1 TC - 99m Market, 2013 - 2025 (USD Million)
      • 8.1.1.5 TL - 201
      • 8.1.1.5.1 TL - 201 Market, 2013 - 2025 (USD Million)
      • 8.1.1.6 GA - 67
      • 8.1.1.6.1 GA - 67 Market, 2013 - 2025 (USD Million)
      • 8.1.1.7 I - 123
      • 8.1.1.7.1 I - 123 Market, 2013 - 2025 (USD Million)
      • 8.1.1.8 Other SPECT Products
      • 8.1.1.8.1 Other SPECT Products Market, 2013 - 2025 (USD Million)
      • 8.1.1.9 PET
      • 8.1.1.10 PET Products Market, 2013 - 2025 (USD Million)
      • 8.1.1.11 F - 18
      • 8.1.1.11.1 F - 18 Market, 2013 - 2025 (USD Million)
      • 8.1.1.12 SR - 82/RB - 82
      • 8.1.1.12.1 SR - 82/RB - 82 Market, 2013 - 2025 (USD Million)
      • 8.1.1.13 Other PET Products
      • 8.1.1.13.1 Other PET Products Market, 2013 - 2025 (USD Million)
      • 8.1.1.2 Therapeutic Products
      • 8.1.1.2.1 Therapeutic Products Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.2 Alpha Emitters
      • 8.1.1.2.3 Alpha Emitters Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.4 RA - 223
      • 8.1.1.2.4.1 RA - 223 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.5 Other Alpha Emitters
      • 8.1.1.2.5.1 Other Alpha Emitters Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.6 Beta Emitters
      • 8.1.1.2.1.7 Beta Emitters Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.8 I - 131
      • 8.1.1.2.8.1 I - 131 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.9 Y - 90
      • 8.1.1.2.9.1 Y - 90 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.10 SM - 153
      • 8.1.1.2.10.1 SM - 153 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.11 Re - 186
      • 8.1.1.2.11.1 Re - 186 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.12 Lu - 117
      • 8.1.1.2.12.1 Lu - 177 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.13 Other Beta Emitters
      • 8.1.1.2.13.1 Other Beta Emitters Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.14 Brachytherapy
      • 8.1.1.2.1.15 Brachytherapy Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.16 Cesium - 131
      • 8.1.1.2.16.1 Cesium - 131 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.17 Iodine - 125
      • 8.1.1.2.17.1 Iodine - 125 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.18 Palladium - 103
      • 8.1.1.2.18.1 Palladium - 103 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.19 Iridium - 192
      • 8.1.1.2.19.1 Iridium - 192 Market, 2013 - 2025 (USD Million)
      • 8.1.1.2.1.20 Other Brachytherapy Products
      • 8.1.1.2.20.1 Other Brachytherapy Products Market, 2013 - 2025 (USD Million)

Chapter 9 Application Mode Business Analysis

  • 9.1 Radiopharmaceuticals Market: Application Movement Analysis.
    • 9.1.1 Diagnostic Application
      • 9.1.1.1 Diagnostic Application Market, 2013 - 2025 (USD Million)
      • 9.1.1.2 Cardiology
      • 9.1.1.3 Cardiology Applications Market, 2013 - 2025 (USD Million)
      • 9.1.1.4 Neurology
      • 9.1.1.5 Neurology Applications Market, 2013 - 2025 (USD Million)
      • 9.1.1.6 Oncology
      • 9.1.1.7 Oncology Applications Market, 2013 - 2025 (USD Million)
      • 9.1.1.8 Thyroid
      • 9.1.1.9 Thyroid Applications Market, 2013 - 2025 (USD Million)
      • 9.1.1.10 Lymphoma
      • 9.1.1.11 Lymphoma Applications Market, 2013 - 2025 (USD Million)
      • 9.1.1.12 Other Diagnostic Application
      • 9.1.1.13 Other Diagnostic Applications Market, 2013 - 2025 (USD Million)
    • 9.1.2 Therapeutic Application
      • 9.1.2.1 Therapeutic Application Market, 2013 - 2025 (USD Million)
      • 9.1.2.2 Thyroid
      • 9.1.2.3 Thyroid Applications Market, 2013 - 2025 (USD Million)
      • 9.1.2.4 Bone Metastasis
      • 9.1.2.5 Bone Metastasis Applications Market, 2013 - 2025 (USD Million)
      • 9.1.2.6 Lymphoma
      • 9.1.2.7 Lymphoma Applications Market, 2013 - 2025 (USD Million)
      • 9.1.2.8 Endocrine Tumor
      • 9.1.2.9 Endocrine Tumor Market, 2013 - 2025 (USD Million)
      • 9.1.2.10 Other Therapeutic Application
      • 9.1.2.11 Other Therapeutic Applications Market, 2013 - 2025 (USD Million)

Chapter 10 Regional Business Analysis

  • 10.1 Radiopharmaceuticals Market: Regional Movement Analysis
    • 10.1.1 North America
      • 10.1.1.1 North America Market Estimates And Forecast, 2013 - 2025
      • 10.1.1.2 U.S.
      • 10.1.1.2.1 U.S. Market Estimates And Forecast, 2013 - 2025
      • 10.1.1.3 Canada
      • 10.1.1.3.1 Canada Market Estimates And Forecast, 2013 - 2025
    • 10.1.2 Europe
      • 10.1.2.1 Europe Market Estimates And Forecast, 2013 - 2025
      • 10.1.2.2 Germany
      • 10.1.2.2.1 Germany Market Estimates And Forecast, 2013 - 2025
      • 10.1.2.3 U.K.
      • 10.1.2.3.1 U.K. Market Estimates And Forecast, 2013 - 2025
      • 10.1.2.4 France
      • 10.1.2.4.1 France Market Estimates And Forecast, 2014 - 2025
      • 10.1.2.5 Italy
      • 10.1.2.5.1 Italy Market Estimates And Forecast, 2013 - 2025
      • 10.1.2.6 Spain
      • 10.1.2.6.1 Spain Market Estimates And Forecast, 2013 - 2025
      • 10.1.2.7 Russia
      • 10.1.2.7.1 Russia Market Estimates And Forecast, 2013 - 2025
      • 10.1.2.8 Netherlands
      • 10.1.2.8.1 Netherlands Market Estimates And Forecast, 2013 - 2025
    • 10.1.3 Asia Pacific
      • 10.1.3.1 Asia Pacific Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.2 Japan
      • 10.1.3.2.1 Japan Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.3 China.
      • 10.1.3.3.1 China Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.1.4 India
      • 10.1.3.1.4.1 India Market Estimates And Forecast, 2014 - 2025
      • 10.1.3.1.5 Australia
      • 10.1.3.1.5.1 Australia Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.1.6 Singapore
      • 10.1.3.1.6.1 Singapore Market Estimates And Forecast, 2014 - 2025
      • 10.1.3.1.7 Malaysia
      • 10.1.3.1.7.1 Malaysia Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.1.8 New Zealand
      • 10.1.3.1.8.1 New Zealand Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.1.9 Korea
      • 10.1.3.1.9.1 Korea Market Estimates And Forecast, 2013 - 2025
      • 10.1.3.1.10 Philippines
      • 10.1.3.1.10.1 Philippines Market Estimates And Forecast, 2013 - 2025
    • 10.1.4 Latin America
      • 10.1.4.1 Latin America Market Estimates And Forecast, 2013 - 2025
      • 10.1.4.2 Brazil
      • 10.1.4.2.1 Brazil Market Estimates And Forecast, 2013 - 2025
      • 10.1.4.3 Mexico
      • 10.1.4.3.1 Mexico Market Estimates And Forecast, 2013 - 2025
      • 10.1.4.4 Argentina
      • 10.1.4.4.1 Argentina Market Estimates And Forecast, 2013 - 2025
    • 10.1.5 Middle East & Africa
      • 10.1.5.1 Middle - East And Africa Market Estimates And Forecast, 2013 - 2025
      • 10.1.5.2 Saudi Arabia
      • 10.1.5.2.1 Saudi Arabia Market Estimates And Forecast, 2013 - 2025
      • 10.1.5.3 South Africa
      • 10.1.5.3.1 South Africa Market Estimates And Forecast, 2013 - 2025
      • 10.1.5.4 Israel
      • 10.1.5.4.1 Israel Market Estimates And Forecast, 2013 - 2025
      • 10.1.5.1.5 Turkey
      • 10.1.5.5.1 Turkey Market Estimates And Forecast, 2013 - 2025

Chapter 11 Company Profile

  • 11.1 Eckert & Ziegler Group
    • 11.1.1 Company Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Benchmarking
    • 11.1.4 Strategic Initiatives
  • 11.2 Mallinckrodt
    • 11.2.1 Company Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Benchmarking
    • 11.2.4 Strategic Initiatives
  • 11.3 GE Healthcare
    • 11.3.1 Company Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Benchmarking
  • 11.4 Jubilant Life Sciences Ltd.
    • 11.4.1 Company Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Benchmarking
    • 11.4.4 Strategic Initiatives
  • 11.5 Bracco Imaging S.P.A
    • 11.5.1 Company Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Benchmarking
    • 11.5.4 Strategic Initiatives
  • 11.6 Nordion, Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Benchmarking
    • 11.6.4 Strategic Initiatives
  • 11.7 The Institute For Radioelements (IRE)
    • 11.7.1 Company Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Benchmarking
    • 11.7.4 Strategic Initiatives
  • 11.8 Australian Nuclear Science & Technology Organization (ANSTO)
    • 11.8.1 Company Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Benchmarking
  • 11.9 NTP Radioisotopes SOC Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Benchmarking
    • 11.9.4 Strategic Initiatives
  • 11.10 Eczacibasi - Monrol
    • 11.10.1 Company Overview
    • 11.10.2 Financial Performance
    • 11.10.3 Product Benchmarking

Chapter 12 KOL Commentary

  • 12.1 Key Insights
  • 12.2 KOL Views

Chapter 13 Recommendations

Back to Top